4.6 Article

The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis

Related references

Note: Only part of the references are listed.
Letter Medicine, General & Internal

Sirolimus treatment for pulmonary lymphangioleiomyomatosis

Camille Taille et al.

ANNALS OF INTERNAL MEDICINE (2007)